Advances in adjuvant therapy for operable N2 non-small cell lung cancer: a narrative review
Non-small cell lung cancer (NSCLC) is still the disease with the highest incidence rate among malignant tumors, in which NSCLC under N2 stage has obvious survival differences among different patients due to its high heterogeneity. For NSCLC under this stage, the current treatment options are: preope...
Saved in:
| Main Authors: | Lei Liu, Yilong Mao, Leilei Guo, Chencong Li, Yiqian Wang |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2025-01-01
|
| Series: | Frontiers in Oncology |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fonc.2024.1523743/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Is postoperative radiotherapy effective in patients with completely resected pathologic stage IIIA(N2) non-small cell lung cancer? High-risk populations should consider it
by: Shu-Xian Zhang, et al.
Published: (2025-01-01) -
Current problems of postoperative radiotherapy for non-small cell lung cancer
by: S. D. Trotsenko, et al.
Published: (2016-02-01) -
In‐Depth Analysis of the Necessity and Optimization Strategies for Adjuvant Radiotherapy Following Neoadjuvant Immunotherapy in the New Era of Esophageal Cancer Treatment
by: Guohui Liu, et al.
Published: (2025-06-01) -
Postoperative radiotherapy improves survival in completely resected non-small cell lung cancer with pathologic N2 stage IIIA and positive lymph node count greater than one: a SEER-based retrospective cohort study
by: Diyang Zhu, et al.
Published: (2025-02-01) -
Postoperative intensity‐modulated radiation therapy reduces local recurrence and improves overall survival in III‐N2 non‐small‐cell lung cancer: A single‐center, retrospective study
by: Wei Wei, et al.
Published: (2020-04-01)